Remuneration

Principles for remuneration and other terms of employment for corporate management.

The annual meeting defines principles for remuneration of the corporate management. The recommendation is drawn up by the remuneration committee.

The main principle is that Devyser shall offer terms appropriate to the market which make it possible for the corporation to recruit and retain competent personnel. Remuneration of the company management shall consist of fixed salary, variable remuneration, a long-term incentive program, retirement benefits and other normal benefits.

The remuneration is based on the commitment and performance of the individual with respect to the goals established beforehand, both individually and collectively for the entire company. Evaluation of the individual performance takes place continuously.

Devyser has four outstanding incentive programs for employees and key personnel.

2023/2027 employee stock option plan
The total plan comprises 200,000 employee stock options, plus 62,840 options for the hedging of social security contributions. The options are granted free of charge. Each option entitles its holder to subscribe for one new share at SEK 101.71 per share until June 2027. The options are vested at a rate of one-third annually starting from the grant date, provided that the holder remains an employee. As of June 30, 2026, a total of 80,268 options had been granted and not exercised. Three members of the senior management together hold a total of 70,000 employee stock options.

2024/2028 employee stock option plan
The total plan comprises 200,000 employee stock options, plus 62,840 options for the hedging of social security contributions. The options are granted free of charge. Each option entitles its holder to subscribe for one new share at SEK 136.48 per share until June 2028. The options are vested at a rate of one-third annually starting from the grant date, provided that the holder remains an employee. As of June 30, 2026, a total of 127,085 options had been granted and not exercised. Five members of the senior management together hold a total of 83,000 employee stock options.

2025/2029 employee stock option plan
The total plan comprises 200,000 employee stock options, plus 62,840 options for the hedging of social security contributions. The options are granted free of charge. Each option entitles its holder to subscribe for one new share at SEK 186.24 per share until September 2029. The options are vested at a rate of one-third annually starting from the grant date, provided that the holder remains an employee. As of June 30, 2026, a total of 161,300 options had been granted and not exercised. CEO Jan Wahlström holds 60,000 options. Five members of the senior management together hold a total of 50,000 employee stock options.

Long-term performance-based compensation plan 2026/2029
At the Annual General Meeting in May, a resolution was passed to introduce a new long-term performance-based compensation plan. The total plan comprises 75,000 warrants, plus 23,565 options for the hedging of social security contributions. The options will be granted as stock options free of charge and vest over a period of 3 years from the grant date, following a performance review, provided that the holder remains an employee. The performance conditions will have three components: the meeting of sales growth targets, the meeting of profitability targets, and the meeting of the target number of tests administered to patients, during the fiscal years 2026, 2027, and 2028, and will be evaluated annually by the Board of Directors. Shares will be granted in 2029 after the end of the vesting period, provided that the conditions have been met. As of June 30, 2026, a total of 0 stock options had been granted and not exercised.